Study Utilizing Rilonacept in Gout Exacerbations

Clinical trial NCT00855920 · COMPLETED

Trial details

NCT number: NCT00855920
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Gout Flare

Start date: 2009-03-01
Primary completion: 2010-02-01
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.